Skip to Main content Skip to Navigation
Journal articles

Biomimetic Glyconanoparticle Vaccine for Cancer Immunotherapy

Abstract : Cancer immunotherapy aims to harness the immune system to combat malignant processes. Transformed cells harbor diverse modifications that lead to formation of neoantigens, including aberrantly expressed cell surface carbohydrates. Targeting tumor-associated carbohydrate antigens (TACA) hold great potential for cancer immunotherapy. N-glycolylneuraminic acid (Neu5Gc) is a dietary non-human immunogenic carbohydrate that accumulates on human cancer cells, thereby generating neoantigens. In mice, passive immunotherapy with anti-Neu5Gc antibodies inhibits growth of Neu5Gc-positive tumors. Here, we designed an active cancer vaccine immunotherapy strategy to target Neu5Gc-positive tumors. We generated biomimetic glyconanoparticles using engineered αGal knockout porcine red blood cells to form nanoghosts (NGs) that either express (NG[pos]) or lack expression (NG[neg]) of Neu5Gc-glycoconjugates in their natural context. We demonstrated that optimized immunization of "human-like" Neu5Gc-deficient Cmah[−/−] mice with NG[pos] glyconanoparticles induce a strong, diverse and persistent anti-Neu5Gc IgG immune response. The resulting anti-Neu5Gc IgG antibodies were also detected within Neu5Gc-positive tumors and inhibited tumor growth in vivo. Using detailed glycan microarray analysis, we further demonstrate that the kinetics and quality of the immune responses influence the efficacy of the vaccine. These findings reinforce the potential of TACA neoantigens and the dietary non-human sialic acid Neu5Gc, in particular, as immunotherapy targets.
Document type :
Journal articles
Complete list of metadata

Cited literature [79 references]  Display  Hide  Download
Contributor : Sylvie Le Bihan Connect in order to contact the contributor
Submitted on : Wednesday, June 19, 2019 - 3:26:26 PM
Last modification on : Wednesday, April 27, 2022 - 4:43:51 AM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document




Eliran Moshe Reuven, Shani Leviatan Ben-Arye, Hai yu, Roberto Duchi, Andrea Perota, et al.. Biomimetic Glyconanoparticle Vaccine for Cancer Immunotherapy. ACS Nano, American Chemical Society, 2019, 13 (3), pp.2936-2947. ⟨10.1021/acsnano.8b07241⟩. ⟨inserm-02160337⟩



Record views